Oscar Health CEO Buys $11.9 Million of Stock
Oscar Health CEO bought $11.9M in shares after stock payout, showing strong confidence. Shares jumped.
Oscar Health CEO bought $11.9M in shares after stock payout, showing strong confidence. Shares jumped.
Raymond James upgrades Oscar Health stock to Outperform with $18 target, calling valuations attractive as margins improve in ACA market and forward outlook strengthens.
Oscar Health reports wider quarterly losses due to higher medical costs, while revenue grows and the company targets profitability in 2026.
Trump's CMS proposes minimal 0.09% Medicare payment increase for 2027, far below Wall Street's 4-6% expectations, while eliminating controversial billing practices.
Barclays upgraded Oscar Health to Equal Weight, raising its price target to $18 as analysts see margin expansion and renewed interest in managed care stocks in 2026.
Over 20 million Americans face sharply higher health insurance costs after the Senate rejected both Republican and Democratic plans to extend expiring Affordable Care Act tax credits.